Company intelligence / Profile preview

Cyrus Poonawalla Group

Pune, Maharashtra, Indiacyruspoonawallagroup.com ↗

Ownership: Private
Development stage: Commercial

Overview

The Serum Institute of India (SII), a key subsidiary, is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses). SII produced Covishield (AstraZeneca COVID-19 vaccine) with over 1 billion doses shipped globally. The company recently received European Commission Marketing Authorization for SIILTIBCY, a novel tuberculosis skin test in Europe.

Therapeutic areas: Infectious Diseases
Modalities: VaccinesImmunobiologicals
Industry: Pharma

Drug pipeline

4 assets

COVISHIELD

Commercial

Indications: COVID-19

3 more assets in the full pipeline.

Request access →

Partnerships

AstraZeneca (for COVID-19 vaccine)Panchshil Realty

Beyond the preview

Go deeper on Cyrus Poonawalla Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyrus Poonawalla Group.

Explore the full profile